The FGFR2 gene has been identified as a locus associated with an increased risk of developing breast cancer, and a single nucleotide polymorphism in the FGFR2 gene, which enhances RUNX2 binding, increases FGFR2 expression54–57. The gene discussed is RUNX2; the disease is breast cancer.